中文(ZH) 港股通标的证券名单调入可孚医疗、经纬天地（新）

深交所调整港股通标的证券名单，可孚医疗、经纬天地调入

By PulseAugur Editorial · [1 sources] · 2026-05-06 00:51

The Shenzhen Stock Exchange announced adjustments to the Hong Kong Stock Connect (港股通) eligible securities list, effective May 6, 2026. Koford Medical (01187) and Jingwei Tiandi (02477) will be added to the list. This adjustment is due to Koford Medical not having a price stabilization mechanism on the Hong Kong Stock Exchange and Jingwei Tiandi beginning parallel trading of split shares. Additionally, the Shanghai and Shenzhen stock exchanges reported a net decrease in margin trading balances, totaling 16.742 billion yuan. AI

RANK_REASON This is a significant adjustment to a major financial market's trading eligibility list. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

other

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

36氪 (36Kr) TIER_1 中文(ZH) · 2026-05-06 00:51

Hong Kong Stock Connect Eligible Securities List Adds Canbridge Pharmaceuticals, China Information Technology Development (New)

36氪获悉，深交所公告，因可孚医疗（01187）在香港联合交易所有限公司上市不适用价格稳定期机制且相应A股上市满10个交易日、经纬天地（02477）开始并行买卖分拆股份，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2026年5月6日起生效，调入可孚医疗、经纬天地（新）。

COVERAGE [1]

Hong Kong Stock Connect Eligible Securities List Adds Canbridge Pharmaceuticals, China Information Technology Development (New)

RELATED ENTITIES

RELATED TOPICS